博瑞医药: 2024年度独立董事述职报告-RUYI HE（何如意）

Core Viewpoint - The independent director of Borui Biopharmaceuticals (Suzhou) Co., Ltd. has reported on their performance during the 2024 term, emphasizing adherence to legal regulations and commitment to protecting the interests of the company and its shareholders, particularly minority shareholders [1][2]. Group 1: Independent Director's Basic Information - The independent director, Ruyi He, has a strong professional background, including roles at various prestigious institutions and currently serves as the Chief Scientist at Guotou Innovation Medical Health [1]. - Ruyi He maintains independence by not holding any other positions within the company or its major shareholders, ensuring objective judgment [1]. Group 2: Attendance and Participation - Throughout the term, the independent director attended all required meetings, including board meetings and special committees, demonstrating diligence and responsibility [2]. - The independent director voted in favor of all proposals during the meetings held in the reporting period [2]. Group 3: Communication and Company Support - The independent director maintained effective communication with the company's board and management, providing insights on strategic planning and industry trends [4]. - The company provided necessary materials and timely responses to inquiries, facilitating the independent director's responsibilities [4]. Group 4: Exercise of Independent Director Powers - During the 2024 term, the independent director did not exercise specific powers such as proposing the hiring of external consultants or calling for extraordinary shareholder meetings [4]. Group 5: Focus on Key Issues - The independent director reviewed related party transactions, confirming their compliance with the company's operational needs and fairness to all shareholders [5]. - The independent director participated in the nomination and review of candidates for the board, ensuring thorough evaluation of qualifications [6]. Group 6: Overall Evaluation and Recommendations - The independent director's contributions were noted as significant in protecting the interests of all shareholders, particularly minority shareholders, and promoting sustainable company development [6].